| Scenic City Alliance Of Psychiatry And Psychotherapy Pllc | |
|
7345 Courage Way Chattanooga TN 37421-1555 | |
| (423) 602-9797 | |
| Not Available |
| Full Name | Scenic City Alliance Of Psychiatry And Psychotherapy Pllc |
|---|---|
| Speciality | Clinic/Center |
| Location | 7345 Courage Way, Chattanooga, Tennessee |
| Authorized Official Name and Position | Oliver Gregory (PRESIDENT/OWNER) |
| Authorized Official Contact | 4236029797 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Scenic City Alliance Of Psychiatry And Psychotherapy Pllc 7345 Courage Way Chattanooga TN 37421-1555 Ph: (423) 602-9797 | Scenic City Alliance Of Psychiatry And Psychotherapy Pllc 7345 Courage Way Chattanooga TN 37421-1555 Ph: (423) 602-9797 |
| NPI Number | 1144788753 |
|---|---|
| Provider Enumeration Date | 03/04/2019 |
| Last Update Date | 06/26/2019 |
| Medicare PECOS PAC ID | 1355670746 |
|---|---|
| Medicare Enrollment ID | O20190910003254 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144788753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Oliver Gregory |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1588772545 PECOS PAC ID: 7012172331 Enrollment ID: I20120711000259 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Andres M Fraga |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508330150 PECOS PAC ID: 3274865498 Enrollment ID: I20191021002469 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Yaniz Seeley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043770233 PECOS PAC ID: 3476975061 Enrollment ID: I20200629001381 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Bonnie A Kidd |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861067183 PECOS PAC ID: 4082018031 Enrollment ID: I20210812001889 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Erin Michelle Lawson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861068439 PECOS PAC ID: 8628472693 Enrollment ID: I20210812002960 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Erica Lynn Winter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487258794 PECOS PAC ID: 5496147357 Enrollment ID: I20220126002322 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Stephanie Elizabeth Bolton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275179574 PECOS PAC ID: 8224425566 Enrollment ID: I20220505000074 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Renee Hall |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316671217 PECOS PAC ID: 1052796034 Enrollment ID: I20220912000983 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Brittany Huffman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043938822 PECOS PAC ID: 7315323557 Enrollment ID: I20220926002716 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
| Provider Name | Eva Marie Coleman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528766797 PECOS PAC ID: 8123484417 Enrollment ID: I20230511000392 |
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
News Archive
The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia (CML) may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
› Verified 6 days ago
Serenity Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3146 Broad St, Chattanooga, TN 37408 Phone: 423-800-0483 Fax: 423-521-8088 | |
Aim Center, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 472 W Ml King Blvd, Chattanooga, TN 37402 Phone: 423-624-4800 Fax: 423-648-9135 | |
Siskin Hospital For Physical Rehabilitation Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Siskin Plz, Chattanooga, TN 37403 Phone: 423-634-1200 Fax: 423-634-4587 | |
Advanced Behavioral-emotional Care Services, Llc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 W Ml King Blvd Ste 1000, Chattanooga, TN 37402 Phone: 704-771-4633 | |
Faraday Health-chattanooga, Tn Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 6031 Shallowford Rd Ste 113, Chattanooga, TN 37421 Phone: 423-825-8500 Fax: 800-878-9297 | |
Trauma And Addiction Recovery Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6727 Heritage Business Ct Ste 718, Chattanooga, TN 37421 Phone: 423-240-0581 | |
Parkridge Valley Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2200 Morris Hill Rd, Chattanooga, TN 37421 Phone: 423-499-2384 |